Showing 148,641 - 148,660 results of 229,329 for search '(( 5 ((step decrease) OR (mean decrease)) ) OR ( 10 ((we decrease) OR (a decrease)) ))', query time: 2.74s Refine Results
  1. 148641

    Data_Sheet_1_Near Complete Repair After Myocardial Infarction in Adult Mice by Altering the Inflammatory Response With Intramyocardial Injection of α-Gal Nanoparticles.docx by Uri Galili (11328408)

    Published 2021
    “…In contrast, mice treated with α-gal nanoparticles demonstrated after 28-days a marked reduction in infarct size (~10-fold smaller), restoration of normal myocardium structure and contractile function.…”
  2. 148642

    Image_4_Tetracyclines Diminish In Vitro IFN-γ and IL-17-Producing Adaptive and Innate Immune Cells in Multiple Sclerosis.jpeg by Despoina T. Florou (11759171)

    Published 2021
    “…</p>Results<p>Both tetracyclines significantly decreased, in a dose dependent manner, IFN-γ production in NKT and CD4<sup>+</sup> T lymphocytes from MS patients (naïve or treated) stimulated with IL-12/IL-18 but did not decrease IFN-γ producing CD8<sup>+</sup> T cells from naive MS or treated RRMS patients. …”
  3. 148643

    Lifespan of long-lived mitochondrial mutants is dependent on DAF-16 interacting proteins IMB-2, CST-1/CST-2 and BAR-1. by Megan M. Senchuk (4925752)

    Published 2018
    “…<p>Decreasing the expression of the transportin-1 homolog <i>imb-2</i> by RNAi decreases the lifespan of <i>clk-1</i> (<b>A</b>), <i>isp-1</i> (<b>B</b>)and <i>nuo-6</i> (<b>C</b>) mutants. …”
  4. 148644

    DataSheet1_One-dimensional modeling of heterogeneous catalytic chemical looping steam methane reforming in an adiabatic packed bed reactor.pdf by Haris Qayyum (17415264)

    Published 2023
    “…At the optimum temperature (950 K), pressure (1 bar), and steam-to-carbon molar ratio (3/1), with an increase in particle diameter from 0.7 to 1 mm, an 18% decrease in methane conversion and a 9.5% increase in hydrogen yield were observed. …”
  5. 148645

    Image_6_Tetracyclines Diminish In Vitro IFN-γ and IL-17-Producing Adaptive and Innate Immune Cells in Multiple Sclerosis.jpeg by Despoina T. Florou (11759171)

    Published 2021
    “…</p>Results<p>Both tetracyclines significantly decreased, in a dose dependent manner, IFN-γ production in NKT and CD4<sup>+</sup> T lymphocytes from MS patients (naïve or treated) stimulated with IL-12/IL-18 but did not decrease IFN-γ producing CD8<sup>+</sup> T cells from naive MS or treated RRMS patients. …”
  6. 148646

    Image_7_Tetracyclines Diminish In Vitro IFN-γ and IL-17-Producing Adaptive and Innate Immune Cells in Multiple Sclerosis.jpeg by Despoina T. Florou (11759171)

    Published 2021
    “…</p>Results<p>Both tetracyclines significantly decreased, in a dose dependent manner, IFN-γ production in NKT and CD4<sup>+</sup> T lymphocytes from MS patients (naïve or treated) stimulated with IL-12/IL-18 but did not decrease IFN-γ producing CD8<sup>+</sup> T cells from naive MS or treated RRMS patients. …”
  7. 148647

    Image_1_Tetracyclines Diminish In Vitro IFN-γ and IL-17-Producing Adaptive and Innate Immune Cells in Multiple Sclerosis.jpeg by Despoina T. Florou (11759171)

    Published 2021
    “…</p>Results<p>Both tetracyclines significantly decreased, in a dose dependent manner, IFN-γ production in NKT and CD4<sup>+</sup> T lymphocytes from MS patients (naïve or treated) stimulated with IL-12/IL-18 but did not decrease IFN-γ producing CD8<sup>+</sup> T cells from naive MS or treated RRMS patients. …”
  8. 148648

    DataSheet1_Building Structure-Property Relationships of Cycloalkanes in Support of Their Use in Sustainable Aviation Fuels.docx by Alexander Landera (1958899)

    Published 2022
    “…Further, our data set includes cycloalkanes drawn from the following structural groups: fused cycloalkanes, n-alkylcycloalkanes, branched cycloalkanes, multiple substituted cycloalkanes, and cycloalkanes with different ring sizes. In addition, a select number of cycloalkanes are blended into Jet-A fuel (POSF-10325) at 10 and 30 wt%. …”
  9. 148649

    Image_3_Tetracyclines Diminish In Vitro IFN-γ and IL-17-Producing Adaptive and Innate Immune Cells in Multiple Sclerosis.jpeg by Despoina T. Florou (11759171)

    Published 2021
    “…</p>Results<p>Both tetracyclines significantly decreased, in a dose dependent manner, IFN-γ production in NKT and CD4<sup>+</sup> T lymphocytes from MS patients (naïve or treated) stimulated with IL-12/IL-18 but did not decrease IFN-γ producing CD8<sup>+</sup> T cells from naive MS or treated RRMS patients. …”
  10. 148650

    Image_5_Tetracyclines Diminish In Vitro IFN-γ and IL-17-Producing Adaptive and Innate Immune Cells in Multiple Sclerosis.jpeg by Despoina T. Florou (11759171)

    Published 2021
    “…</p>Results<p>Both tetracyclines significantly decreased, in a dose dependent manner, IFN-γ production in NKT and CD4<sup>+</sup> T lymphocytes from MS patients (naïve or treated) stimulated with IL-12/IL-18 but did not decrease IFN-γ producing CD8<sup>+</sup> T cells from naive MS or treated RRMS patients. …”
  11. 148651

    Image_2_Tetracyclines Diminish In Vitro IFN-γ and IL-17-Producing Adaptive and Innate Immune Cells in Multiple Sclerosis.jpeg by Despoina T. Florou (11759171)

    Published 2021
    “…</p>Results<p>Both tetracyclines significantly decreased, in a dose dependent manner, IFN-γ production in NKT and CD4<sup>+</sup> T lymphocytes from MS patients (naïve or treated) stimulated with IL-12/IL-18 but did not decrease IFN-γ producing CD8<sup>+</sup> T cells from naive MS or treated RRMS patients. …”
  12. 148652

    Image_8_Tetracyclines Diminish In Vitro IFN-γ and IL-17-Producing Adaptive and Innate Immune Cells in Multiple Sclerosis.jpeg by Despoina T. Florou (11759171)

    Published 2021
    “…</p>Results<p>Both tetracyclines significantly decreased, in a dose dependent manner, IFN-γ production in NKT and CD4<sup>+</sup> T lymphocytes from MS patients (naïve or treated) stimulated with IL-12/IL-18 but did not decrease IFN-γ producing CD8<sup>+</sup> T cells from naive MS or treated RRMS patients. …”
  13. 148653

    Necroptosis sensitivity screen in 941 cancer cell lines identifies drivers of necroptosis resistance. by Ayaz Najafov (322631)

    Published 2018
    “…The underlying data can be found in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.2005756#pbio.2005756.s001" target="_blank">S1 Data</a>. p-MLKL, phospho-MLKL S358; TSZ TNFα+SM-164+zVAD.fmk; UT, untreated.…”
  14. 148654

    <i>Ezh1</i> and <i>Ezh2</i> expression in wild-type pre-pubertal and young adult liver and in E1/E2-KO mouse liver. by Dana Lau-Corona (8861900)

    Published 2020
    “…Primers used are shown in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008796#pgen.1008796.s009" target="_blank">S1A Table</a> and their location marked with green boxes in Fig 1B. …”
  15. 148655

    Posterior distributions of <i>x</i><sub>2</sub>(<i>t</i>) in the two-state model experiments. by Nathaniel J. Linden (11265707)

    Published 2022
    “…<p>(<b>A</b>) corresponds to the measurement noise experiment, <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1010651#pcbi.1010651.g003" target="_blank">Fig 3C</a>. …”
  16. 148656
  17. 148657
  18. 148658
  19. 148659

    Image_2_Symptomatic Premature Ventricular Contractions in Vasovagal Syncope Patients: Autonomic Modulation and Catheter Ablation.tif by Lihui Zheng (10588295)

    Published 2021
    “…PVCs burden of the six patients in whom neither catheter ablation nor antiarrhythmic drugs were applied demonstrated a significant decrease during follow-up (P = 0.037).…”
  20. 148660

    Image_1_Symptomatic Premature Ventricular Contractions in Vasovagal Syncope Patients: Autonomic Modulation and Catheter Ablation.tif by Lihui Zheng (10588295)

    Published 2021
    “…PVCs burden of the six patients in whom neither catheter ablation nor antiarrhythmic drugs were applied demonstrated a significant decrease during follow-up (P = 0.037).…”